By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Developing and commercializing highly differentiated therapies that have a meaningful impact247M100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States247M100.00%